3Martinez-Caceres EM,Barrau MA,Brieva L,et al.Treatment with methylprednisolone in relapse of multiple sclerosis patients:Immunological evidence of immediate and short-term but not long-lasting effects[J].Clin Exp Immunol,2002,127:165-171.
4Verena I,Leussink,Stefan J,et al.High-dose Methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes[J].Arch Neurol,2001,58:91-97.
5Zipp F,Wendling U,Beyer M,et al.Dual effect of gulcocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells[J].J Neuroimmunol,2000,110:214-222.
6Conlon P,Oksenberg JR,Zhang J,et al.The immunobiology of multiple sclerosis:An antoimmune disease of central nervous system[J].Neurobiol Dis,1999,6:149-66.
7Elovaara I,Ukkonen M,Leppakynnas M,et al.Adhension molecules in multiple sclerosis:Relation to subtypes of disease and methylprednisolone therapy[J].Arch Neurol,2000,57:546-551.
8Gelati M,Corsini E,Dofour A,et al.High-dose methylprednisolone reduces cytokine-induced adhesion molecules on human brain endothelium[J].Can J Neurol Sci,2000,27:241-244.
9Yoshida N,Yoshikawa T,Nakamura Y,et al.Methylprednisolone inhibits neutronphil-endothelial cell interactions induced by interleukin-1beta under flow conditions[J].Life Sci,1997,60:2341-2347.
10Vanderheyde N,Verhasselt V.Inhibition of human dendritic cell functions by methylprednisolone[J].Transplantation,1999,67:1342-1347.
5Kono D H, Urban J L, Horrath S J,et al.Two minor determinants of myelin basic prtein induce experimental allergic encephalomyelitis in SJL/J mice[J].J Exp Med, 1988,16(8) :213-227.
6Finkel T. Oxidant signals and oxidative stress[J]. Curr Opin Celt Bial,2003,15 (6) : 247-254.
7Guy J, McGorray S, Fitzsimmons J,et al.Disruption of the bloodbrain barrier in experimental optic neuritis: immunocytochemical colocalization of H2O2 and extravasated serum albumin[J]. Invest Ophthalmol Vis Sci, 1994,35( 3 ) : 1114-1123.
8Guy J, Qi X, Wang H, et al. Adenoviral gene therapy with catalase suppresses experimental optic neuritis[J].Arch Ophthalmol, 1999,117( 11 ) : 1533-1539.
9Elovaara I, Okkonen M, Leppakynnas M, et al.Adhension molecules in multiple sclerosis:Relation to subtypes of disease and methylprednisolone therapy[J].Arch Neurol, 2000,57 (9) : 546-551.
10Valen G, Kawakami T,Tahepold P, et al.Pretreatment with mythylprednisolone protects the isolated rat heart against isehaemic and oxidative damage[J].Free Radic Res, 2000,33( 1 ) :31-43.